These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2066398)
21. Suppression of T lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin. Brown SL; Van Epps DE J Immunol; 1985 May; 134(5):3384-90. PubMed ID: 3156934 [TBL] [Abstract][Full Text] [Related]
22. Participation of thrombospondin-1 in the activation of latent transforming growth factor-beta in malignant glioma cells. Sasaki A; Naganuma H; Satoh E; Kawataki T; Amagasaki K; Nukui H Neurol Med Chir (Tokyo); 2001 May; 41(5):253-8; discussion 258-9. PubMed ID: 11396305 [TBL] [Abstract][Full Text] [Related]
23. Immunobiology of malignant gliomas. Tada M; de Tribolet N J Clin Neurosci; 1996 Apr; 3(2):102-13. PubMed ID: 18638850 [TBL] [Abstract][Full Text] [Related]
25. Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma. Akasaki Y; Liu G; Chung NH; Ehtesham M; Black KL; Yu JS J Immunol; 2004 Oct; 173(7):4352-9. PubMed ID: 15383564 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of immune evasion by gliomas. Rolle CE; Sengupta S; Lesniak MS Adv Exp Med Biol; 2012; 746():53-76. PubMed ID: 22639159 [TBL] [Abstract][Full Text] [Related]
27. Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7. Dubinett SM; Huang M; Dhanani S; Economou JS; Wang J; Lee P; Sharma S; Dougherty GJ; McBride WH J Natl Cancer Inst; 1995 Apr; 87(8):593-7. PubMed ID: 7752257 [TBL] [Abstract][Full Text] [Related]
28. Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors. Morford LA; Dix AR; Brooks WH; Roszman TL J Neurosurg; 1999 Dec; 91(6):935-46. PubMed ID: 10584838 [TBL] [Abstract][Full Text] [Related]
29. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. Bodmer S; Strommer K; Frei K; Siepl C; de Tribolet N; Heid I; Fontana A J Immunol; 1989 Nov; 143(10):3222-9. PubMed ID: 2809198 [TBL] [Abstract][Full Text] [Related]
30. Regulation of human B cell proliferation by prostaglandin E2. Thompson PA; Jelinek DF; Lipsky PE J Immunol; 1984 Nov; 133(5):2446-53. PubMed ID: 6332851 [TBL] [Abstract][Full Text] [Related]
31. [Anti-tumor activity of human recombinant TNF against human malignant glioma cell lines and combined effect with Hu INF-beta]. Enomoto H; Yoshida J; Kageyama N; Ueda R; Kato T; Ota K Gan To Kagaku Ryoho; 1986 May; 13(5):1953-61. PubMed ID: 3085596 [TBL] [Abstract][Full Text] [Related]
32. Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma. Ochs K; Sahm F; Opitz CA; Lanz TV; Oezen I; Couraud PO; von Deimling A; Wick W; Platten M J Neuroimmunol; 2013 Dec; 265(1-2):106-16. PubMed ID: 24090655 [TBL] [Abstract][Full Text] [Related]
33. PGE2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity. Parhar RS; Yagel S; Lala PK Cell Immunol; 1989 Apr; 120(1):61-74. PubMed ID: 2784722 [TBL] [Abstract][Full Text] [Related]
34. Glioma-astrocyte interaction modifies the astrocyte phenotype in a co-culture experimental model. Gagliano N; Costa F; Cossetti C; Pettinari L; Bassi R; Chiriva-Internati M; Cobos E; Gioia M; Pluchino S Oncol Rep; 2009 Dec; 22(6):1349-56. PubMed ID: 19885586 [TBL] [Abstract][Full Text] [Related]
35. In vitro studies of cytokine-mediated interactions between malignant glioma and autologous peripheral blood mononuclear cells. Jachimczak P; Schwulera U; Bogdahn U J Neurosurg; 1994 Oct; 81(4):579-86. PubMed ID: 7931592 [TBL] [Abstract][Full Text] [Related]
36. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages. Alleva DG; Walker TM; Elgert KD J Leukoc Biol; 1995 Jun; 57(6):919-28. PubMed ID: 7790775 [TBL] [Abstract][Full Text] [Related]
37. Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo. Aulwurm S; Wischhusen J; Friese M; Borst J; Weller M Int J Cancer; 2006 Apr; 118(7):1728-35. PubMed ID: 16217761 [TBL] [Abstract][Full Text] [Related]
38. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Bornemann A; Meyermann R; Weiss EH; Melms A; Weller M J Immunol; 2002 May; 168(9):4772-80. PubMed ID: 11971028 [TBL] [Abstract][Full Text] [Related]
39. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model. Ashley DM; Kong FM; Bigner DD; Hale LP Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409 [TBL] [Abstract][Full Text] [Related]
40. NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2. Blom MA; van Twillert MG; de Vries SC; Engels F; Finch CE; Veerhuis R; Eikelenboom P Brain Res; 1997 Nov; 777(1-2):210-8. PubMed ID: 9449430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]